RL
66
-2
NRG
59
-10
CPB
27
-2
LB
38
-3
MCD
54
4
CMA
52
-3
CCI
25
-11
MRO
59
-3
CLX
68
4
ITW
61
2
CSCO
56
3
M
28
-3
JWN
50
-2
AES
31
-9
A
41
7
LH
40
-2
WFC
71
-3
CAT
57
2
D
38
-2
PDCO
36
-2
RL
66
-2
NRG
59
-10
CPB
27
-2
LB
38
-3
MCD
54
4
CMA
52
-3
CCI
25
-11
MRO
59
-3
CLX
68
4
ITW
61
2
CSCO
56
3
M
28
-3
JWN
50
-2
AES
31
-9
A
41
7
LH
40
-2
WFC
71
-3
CAT
57
2
D
38
-2
PDCO
36
-2
Financhill
Back

XTL Biopharmaceuticals 10K Form

Sell
41

XTLB
XTL Biopharmaceuticals

Last Price:
1.88
Seasonality Move:
6.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive XTLB News And Ratings

See the #1 stock for the next 7 days that we like better than XTLB

XTLB Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.50
Price / Book: 3.79

Profitability

EPS (TTM): -0.03130
Net Income (TTM): $-378K
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

XTL Biopharmaceuticals Earnings Forecast

Key XTL Biopharmaceuticals Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 10 years.

XTL Biopharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: XTLB
CUSIP: 98386D
Website: xtlbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

XTLB Technical Analysis vs Fundamental Analysis

Sell
41
XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy or a Sell?